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Abstract
Non-communicable diseases represent one of the greatest challenges for health policymakers. The main objective of
this study is to analyse the development of standardised mortality rates for cerebrovascular disease, which is one of
the most common causes of deaths, in relation to income inequality in individual regions of the Slovak Republic.
Direct standardisation was applied using data from the Slovak mortality database, covering the time period from 1996
to 2013. The standardised mortality rate declined by 4.23% in the Slovak Republic. However, since 1996, the rate has
been higher by almost 33% in men than in women. Standardised mortality rates were lower in the northern part of
the Slovak Republic than in the southern part. The regression models demonstrated an impact of the observed
income-related dimensions on these rates. The income quintile ratio and Gini coefficient appeared to be the most
influencing variables. The results of the analysis highlight valuable baseline information for creating new support
programmes aimed at eliminating health inequalities in relation to health and social policy.
Keywords: Standardised mortality rate, Cerebrovascular diseases, Income inequality, Regional disparities, the Slovak
Republic
Background
The health status of a country’s population is the result
of a complex interplay of genetic features, socio-economic
situations, and environmental, nutritional, and lifestyle
factors, as well as of the general availability of health care
including preventive programmes [1]. The data on mor-
tality are common indicators used to measure and com-
pare a country’s health status at the local, national, and
international level, as these data are regularly and widely
collected. Understanding the health status of a popula-
tion should form the baseline for establishing effective
health policies, allocation of funds, and prioritisation of
health care in the country [2–4]. The Slovak Republic has
currently developed proposals for reforms in the health
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sector, and these changes should be based on relevant
analyses concerning the health status of a population
and demographic indicators. In terms of mortality, it is
desirable to examine the leading causes of death because
these conditions require increased attention from health
policymakers in the Slovak Republic.
The most common causes of death include cardiovascu-
lar diseases, which cause approximately 45% of all deaths
in the Slovak Republic. In particular, ischaemic heart dis-
eases and cerebrovascular diseases are the leading causes
of mortality in the Slovak Republic [5].
TheWorldHealthOrganization defines cerebrovascular
diseases as rapidly developing clinical signs of focal cere-
bral dysfunction that last for more than 24 hours or lead
to death without the presence of an apparent cause other
than cerebrovascular malformations. Ischaemic stroke is
defined as blockage of the blood vessels affecting tissue
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in the central nervous system. Unlike transient ischaemic
attack, ischaemic infarction may be symptomatic or
asymptomatic. Cerebrovascular diseases are a predom-
inant cause of death in developed countries [6]. They
present long-term and significant socio-economic issues
worldwide [7–9]. The incidence of transient ischaemic
attacks in Europe and in the United States is estimated
to range from 0.37 to 1.1 per 1,000 inhabitants per year,
which exponentially increases with age regardless of race
and gender from 6 to 16 per 1,000 inhabitants aged 85
years and older per year [10]. Its prevalence is estimated
to range from 0.4% to 4.1%. In 2002, experts had already
examined the development of the mortality rate due to
cerebrovascular diseases in Europe, the United States,
and in Japan [11, 12]. Their studies confirmed that the
worst results at that time occurred in eastern European
countries. With the increasing life expectancy as well as
the number of elderly, a rise in the prevalence of cere-
brovascular diseases can be expected in many developed
countries.
Despite the advanced multidisciplinary research on
cerebrovascular disease in many countries, respective
analyses are absent for the Slovak Republic. The available
partial analyses of medical fields assess the country’s pop-
ulation health issues separately, in the context of outputs
from various casuistries. They do not provide compre-
hensive or relevant baselines for health and social policy,
because they lack a contextual link with demographic
processes such as the ageing of the population and cor-
relations with socioeconomic characteristics and regional
disparities in health. Knowledge of these determinants,
the causal relations, and their quantification should be
incorporated into targeted research studies and would
provide important information for many policymakers as
well as for the creation of targeted metrics represent-
ing the health status of the Slovak population within the
strategic framework of the healthcare system. A systemic
problem that occurs with prevention programmes is that
if they are not properly targeted or are implemented with
inappropriate tools, they lose their primary effect, and
thus efforts to increase the effectiveness of the health
system do not achieve the desired countrywide results.
The situation outside of the Slovak Republic is far more
positive. Multidimensional analyses of mortality and its
determinants have long been at the heart of many disci-
plines, including the medical, economic, social sciences.
This is clearly evidenced by the quality of the available
epidemiological scientific research studies [13, 14] as well
as the further development of similar fields [15–20]. In
addition to scientific research institutions, the issue of
morbidity and mortality is also explored by international
institutions – for instance, the World Health Organiza-
tion, Eurostat, and the Organisation for Economic Co-
operation and Development [6].
The aim of this study is to identify the most vulner-
able groups of people in the past 17 years and to find
the regions of the Slovak Republic with the highest cere-
brovascular disease mortality rate while considering the
income inequality between regions.
The main objectives of this study are as follows:
• To analyse the progression of mortality rate due to
cerebrovascular diseases in the Slovak Republic in
comparison with selected European countries;
• To reveal regional differences, both in the level and
progression of the cerebrovascular disease mortality
rate, in the Slovak Republic;
• To quantify the relationship between the mortality
rate and income indicators in the individual regions
of the Slovak Republic.
The main contribution of this study is the identifica-
tion of regional discrepancies in the mortality rate of
cerebrovascular diseases in the Slovak Republic and the
analysis of their reasons in relation to each region’s income
indicators. When examining the relationship between
mortality and income indicators, we expected to observe
a positive linear relationship between mortality and the
explored indicators – unemployment rate, poverty, Gini
coefficient, social benefits, and income quintile ratio. On
the contrary, a negative linear relationship was expected
for disposable income.
Methods
The data and methodology section offers an overview of
the applied dataset and methodology.
Data
The mortality rate was computed from data on the num-
ber of deaths due to cerebrovascular diseases – marked as
codes I60 to I69 – according to sex, five-year age groups
and individual regions of the Slovak Republic from 1996 to
2013. Under the conditions of their contract, the National
Health Information Centre (Národné centrum zdravot-
níckych informàcií) of the Slovak Republic provides a
primary source of data on national health statistics.
Mid-year population data by sex, age group and indi-
vidual region for all explored years were obtained from
the Statistical Office of the Slovak Republic (Štatistický
úrad Slovenskej Republiky). Mortality rate was age-
standardised to the revised European standard popula-
tion by the age groups adopted by Eurostat in the last
revision in 2012. For international comparisons, coun-
tries with extreme cerebrovascular disease mortality rates
were selected, as were countries of the Visegrad Group
– the Czech Republic, Hungary, Poland, and the Slovak
Republic, which show similarities due to their shared post-
socialist development. The data were available from 2004
to 2012.
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In particular regions of the Slovak Republic, we tested
the relationship between the standardised mortality rate
and the following socio-economic indicators:
• Unemployment rate – expressed as the share of
unemployed inhabitants of the number of
economically active inhabitants in the previous year;
• Disposable income of a household – the mean
equivalised net income per household – expressed in
EUR per month;
• Poverty – the share of the population with an income
lower than the at-risk-of-poverty threshold compared
to the whole population;
• Gini coefficient;
• Income quintile ratio – S80/S20 ratio;
• Social benefits – the amount of all social benefits
received by an individual – expressed in EUR per
month.
The data on unemployment rate were obtained from
the Statistical Office of the Slovak Republic, and the other
indicators were downloaded from the European Union
Statistics on Income and Living Conditions, which is the
most extensive statistical survey on income, living condi-
tions and poverty indicators in the European Union from
2004 to 2013.
There are a few notes to consider regarding the defini-
tion of the chosen income indicators. The unemployment
rate indicates the ratio of the number of unemployed
inhabitants out of the number of economically active
inhabitants in the previous year. The mean equivalised
net income per household represents the household dis-
posable income divided by the equivalent household size.
Individual household members are assigned weights – 1
for the first adult household member, 0.5 per each addi-
tional adult member, 0.5 per each adolescent 14 years of
age and over and 0.3 per each child younger than 14 years
of age. The at-risk-of-poverty threshold is set at 60% of
the national median of individual equivalised disposable
income. It expresses the percentage of inhabitants with an
equivalent disposable income below a set boundary.
The Gini coefficient is an indicator of monetary poverty
that represents inequality in income distribution and is
defined as the relationship of cumulative shares of the
population arranged according to the level of equivalised
disposable income compared to the cumulative share of
the equivalised total disposable income they receive. It
ranges in value from 0, meaning absolute income equality
– everyone has the same income – to 1, signalling absolute
income inequality – one person has the entire income and
all others have none. The income quintile ratio – S80/S20
ratio – is a measure of the income distribution inequal-
ity. It is calculated as the proportion of the total income of
20% of the richest people in society – located in the top
quintile – relative to the total income of the 20% poorest
people – located in the lowest quintile. Social benefits
include all types of monetary social help targeted for poor,
disabled, or otherwise handicapped people.
Methodology
To examine the relationships between these variables, we
applied correlation and regression analyses. Through the
regression, we quantified the effect of individual income
indicators functioning as independent variables on the
standardised mortality rate as the dependent variable at a
certain significance level.
The general equation used in regression analysis is as
follows:
Y = β0 +
v∑
i=1
(βiXi) +  (1)
• Y – explained variable;
• β0 – constant;
• v – number of explanatory variables;
• βi – fitted coefficient of the i th explanatory variable,
whilst i ∈ N;
• Xi – the i th explanatory variable;
•  – residual.
In our analysis, we implemented a modelling pro-
cess with an outcome in the form of regression models.
We applied the linear regression method. To determine
the statistical significance of the regression models, four
methods were employed – the coefficient of determina-
tion and its adjusted version, the bayesian information
criterion, and the Akaike information criterion.
The standardised mortality rate SMR serves as an
explanatory variable. It was constructed for cerebrovas-
cular diseases in particular. The explanatory variables
mentioned in the regression analysis are as follows:
• UR – unemployment rate;
• I – mean net disposable income of a household –
expressed in EUR per month;
• P – share of population with an income lower than
the at-risk-of-poverty threshold in relation to the
whole population;
• GC – Gini coefficient;
• IQR – income quintile ratio;
• SB – amount of all social benefits of an individual –
expressed in EUR per month.
Mortality rate was expressed as the standardised mor-
tality rate, which is defined as the number of total deaths
per 100,000 inhabitants. We applied the method of direct
standardisation to eliminate variances resulting from dif-
ferences in the age structure of the populations across
regions and over time, ensuring the necessary conditions
for comparing regions of the Slovak Republic.
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The standardised cerebrovascular disease mortality rate
by sex was calculated for the individual regions of the
Slovak Republic during the period from 1996 to 2013 in
Microsoft Access using Structured Query Language, and
contingency analysis was conducted in Microsoft Excel.
Regression analysis was performed in statistical software
R. The dataset was in the form of time series panel data
combined with cross-sections.
To study the population statistics, we applied descriptive
statistical methods, in particular measures of central ten-
dency – minimum, maximum, mean, median and mode –
and measures of variability – interquartile range, standard
deviation and coefficient of variation.
Results
Development of standardised mortality rates for
cerebrovascular diseases in the selected European Union
members
Cerebrovascular diseases are a leading cause of death
in almost all European Union countries, representing
approximately 11% of all deaths in these countries [21].
The comparability of the data over time and across differ-
ent countries was ensured by Eurostat’s Working Group
on Public Health Statistics. In contrast to the 2004 to 2010
data, the 2011 to 2012 data were collected with a legal
basis [22, 23], however, the comparability of the data was
checked before dissemination.
Figure 1 depicts the progression in the cerebrovascu-
lar disease mortality rate of the European Union countries
with the most extreme values throughout the time period
from 2004 to 2012. The trend in standardised mortal-
ity rate was identified as slightly decreasing, with the
exception of the trend in Bulgaria. The highest percent-
age declines were recorded in countries such as Estonia,
where it reached 63.13%, and the Czech Republic with a
39.74% decline. However, a slight increase at a level of
0.69% was revealed in Bulgaria, while the standardised
mortality rates were on average 3.2 times higher than
the average of the entire European Union. The small-
est decline in standardised mortality rate occurred in the
Slovak Republic, at a level of 4.23%. While the standard-
ised mortality rate of all the observed countries decreased
from 2006 to 2008, the Slovak Republic recorded a very
sharp increase of 42.7%. The average of the entire European
Union was characterised by a relatively high decline in
the standardised mortality rate for cerebrovascular dis-
eases, reaching 31.5%. The Slovak Republic significantly
lagged behind the other countries in improvements in
the mortality rate within a given time span. In the last
year with available statistics, the VisegradGroupmembers
showed standardised mortality rates above the average
of the entire European Union. The Slovak Republic had
the worst standardised mortality rate at 160 per 100,000
inhabitants, followed by Hungary at 158 per 100,000
inhabitants, the Czech Republic at 142 per 100,000 inhab-
itants and finally Poland at 132 per 100,000 inhabitants.
Development of the standardised mortality rate for
cerebrovascular diseases in the Slovak Republic
The focus of further analyses was on the standardised
mortality rate for cerebrovascular diseases in the Slovak
Republic. In the long term, during the period from 1996 to
2013, the trend in standardised mortality rate was cyclical
and slightly decreasing.
The standardised mortality rate for men recorded a
24.99% decrease from 211.92 per 100,000 inhabitants in
1996 to 158.96 per 100,000 inhabitants in 2013, compared
to a 24.09% drop from 165.64 per 100,000 inhabitants in
1996 to 125.73 per 100,000 inhabitants in 2013 for women.
Throughout the period from 1996 to 2013, the standard-
ised mortality rate for men was higher by 33% compared
to the rate among women. A maximum gender gap was
observed in 2007 at a level of 37%, while a minimum
difference of 26% was found in 2013, as seen in Fig. 2.
Fig. 1 Standardised mortality rate per 100,000 inhabitants for cerebrovascular diseases in the selected countries and in the European Union from
2004 to 2012
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Fig. 2 Standardised mortality rate per 100,000 inhabitants for cerebrovascular diseases according to the sexes in the Slovak Republic from 1996 to
2013
Age plays an important role in the analysis of mortal-
ity because it is a significant predictor and an indicator of
at-risk age groups. To eliminate fluctuations in the num-
ber of deaths, the observed period from 1996 to 2013
was divided into the three periods. Each phase covers 6
years. The first period begins in 1996 and ends in 2001,
the second period lasts from 2002 to 2007, and the third
period runs from 2008 to 2013 [24]. The number of deaths
according to age group, represented by the histogram dis-
played in Fig. 3, reflects the observations for the three
different time periods to detect the age group with the
most number of deaths. It shows an exponential growth
in the number of deaths up to the group of 75-year-old
to 79-year-old people for the first time period and up to
the group of 80-year-old to 84-year-old people for the sec-
ond and also the third period. Regarding old age mortality,
negative linear trends in frequencies are demonstrated.
The median standardised mortality rate was set at the
75-year-old to 79-year-old age group, representing 50% of
deaths above this age group. In relation to the advanced
age of death, it can be supposed that the background
or origin of cerebrovascular diseases is chronic in many
cases of death. The interquartile range lies between the
65-year-old to 69-year-old and 80-year-old to 84-year-old
age groups, representing the age characteristics of half
of the deaths in the period from 1996 to 2001. From
2002 to 2013, the first quartile transitioned to the 70-
year-old to 74-year-old age group and the third quartile
did not change, and thus a 50% share of deaths was nar-
rowed down to the age group of 70-year-old to 84-year-old
people.
The results reveal a decreased level of premature mor-
tality for cerebrovascular diseases, which was typically
represented by deaths up to the 75th year of age [25]. This
finding may be partly related to the ageing of the Slovak
population as well as to an increase in life expectancy
at birth from 77.5 years in 2000 to 79.9 years in 2012.
Therefore, in the following analysis, the values of the
Fig. 3 Standardised mortality rate per 100,000 inhabitants for cerebrovascular diseases according to the age groups and the time period in the
Slovak Republic from 1996 to 2013
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standardised mortality rate are considered to eliminate
bias. For a deeper analysis of the mortality caused by
cerebrovascular diseases in the Slovak Republic, it was
desirable to examine regional differences based on sex and
using a long-term approach.
Regional differences in the development of standardised
mortality rate for cerebrovascular diseases in the Slovak
Republic
Based on the Nomenclature of Units for Territorial Statis-
tics geocode standard, the Slovak Republic is divided into
8 geographic regions: the Banská Bystrica Region, the
Bratislava Region, the Košice Region, the Nitra Region,
the Prešov Region, the Trencín Region, the Trnava Region,
and the Žilina Region.
As seen in Table 1, in terms of the individual regions
of the Slovak Republic for men, the standardised mor-
tality rates range from 143.42 per 100,000 inhabitants
in the Prešov Region to 288.73 per 100,000 inhabitants
in the Banská Bystrica Region between 1996 and 2001;
they further vary from 108.57 per 100,000 inhabitants in
the Bratislava Region to 237.10 per 100,000 inhabitants
in the Nitra Region in the period from 2002 to 2007,
and finally from 113.05 per 100,000 inhabitants in the
Žilina Region to 241.8 per 100,000 inhabitants in the Nitra
Region during the last period from 2008 to 2013.
Table 2 reflects the descriptive statistics of standardised
mortality rate in each time period. Throughout the entire
explored time span, the median standardised mortality
rate for men increased from 197.70 per 100,000 inhab-
itants to 205.15 per 100,000 inhabitants, representing a
deterioration in mortality accompanied by considerable
period-over-period increases in the Prešov Region, at lev-
els of 5.39% and 33.84%; in the Košice Region, at levels
of 11.18% and 0.82%; and in the Nitra Region, at levels
Table 2 Descriptive statistics of standardised mortality rates for
cerebrovascular diseases for men in the Slovak Republic
Indicator 1996–2001 2002–2007 2008–2013
Minimum 143.42 108.57 113.05
Maximum 288.73 237.10 241.80
Median 197.70 199.71 205.15
Mean 206.24 188.82 197.54
Standard deviation 45.47 41.71 37.43
Coefficient of variation 22.05 22.09 18.95
Source: based on own elaboration by the authors
of 0.20% and 1.98% between each two successive periods,
respectively, as seen in Table 1. In all three time peri-
ods, the Banská Bystrica Region, the Nitra Region, and the
Trnava Region had a standardisedmortality rate above the
median formen, while the Bratislava Region and the Žilina
Region consistently showed values lower than the median.
Although the standardised mortality rate attained in the
Banská Bystrica Region was high, this region also showed
the greatest progress in improving mortality results. The
reduced variability in standardised mortality rate for cere-
brovascular diseases was confirmed by the values of stan-
dard deviation as well as the coefficient of variation, which
recorded a downward trend throughout the entire time
span, as displayed in Table 2. As for the variability of each
region, the highest value was achieved in the Bratislava
Region, at a level of 26.21. The lowest value, 14.90, was
observed in the Žilina Region. Although the Bratislava
Region could be considered the best in terms of mortal-
ity, the variability results showed quite high volatility in
positive results in this region.
The standardised mortality rate was an average of
33% lower for women than for men. During the period
Table 1 Standardised mortality rate per 100,000 inhabitants for cerebrovascular diseases for men in the regions of the Slovak Republic




SMR Rank SMR Rank Change SMR Rank Change
BC 288.73 8th 218.83 7th −24.21% 208.01 5th −4.94% 20.58
BL 170.40 2nd 108.57 1st −36.29% 113.05 1st 4.13% 26.21
KI 187.03 4th 207.93 5th 11.18% 209.64 6th 0.82% 22.71
NI 236.62 7th 237.10 8th 0.20% 241.80 8th 1.98% 15.90
PV 143.42 1st 151.15 2nd 5.39% 202.30 4th 33.84% 24.99
TA 231.51 6th 214.40 6th −7.39% 217.46 7th 1.43% 15.30
TC 208.38 5th 191.49 4th −8.10% 192.04 2nd 0.29% 16.50
ZI 183.84 3rd 181.14 3rd −1.47% 196.01 3rd 8.21% 14.90
Legend: SMR standardised mortality rate, BC the Banská Bystrica Region, BL the Bratislava Region, KI the Košice Region, NI the Nitra Region, PV the Prešov Region, TA the
Trnava Region, TC the Trencín Region, ZI the Žilina Region
Note: Change is computed as period-over-period change
Source: based on own elaboration by the authors
Gavurová et al. Health Economics Review  (2017) 7:7 Page 7 of 12
from 1996 to 2001, its values for women range from
110.44 per 100,000 inhabitants in the Prešov Region to
227.15 per 100,000 inhabitants in the Banská Bystrica
Region. From 2002 to 2007, the minimum value increased
only to 83.79 per 100,000 inhabitants in the Bratislava
Region. Conversely, the maximum value peaks at a level
of 183.33 per 100,000 inhabitants in the Nitra Region.
In the period from 2008 to 2013, the Bratislava Region
with a value of 89.78 per 100,000 inhabitants remained
the best, compared with the Nitra Region at a level of
183.33 per 100,000 inhabitants, representing the worst
mortality rate of all regions. According to Table 3, the
percentage changes in the standardised mortality rate for
women expose relatively large differences between the
regions. In the period from 2002 to 2007, a majority of
the regions recorded a decline in percentage compared
with the period from 1996 to 2001. The highest percent-
age decreases were recorded in the Bratislava Region, at
a value of 34.64%; in the Banská Bystrica Region, with a
value of 29.94%; and in the Trencín Region, with a value of
17.44%.
Similarly as seen in Table 4, the median standardised
mortality rate falls from 153.41 per 100,000 inhabitants
to 142.90 per 100,000 inhabitants. In the last time period,
the median increases to 151.63 per 100,000 inhabitants.
This trend was accompanied by an increase in the growth
rate of standardised mortality rate in all regions except for
the Košice and Nitra Regions. However, the most growth
occurred in the Prešov Region, at a level of 34.10%. The
Nitra Region showed no change in growth rate, although
it increased during the entire examined time span in the
Košice Region as well as in the Prešov Region. The Banská
Bystrica Region, Nitra Region, and Trnava Region had
a standardised mortality rate above the median, while
the Bratislava Region and the Žilina Region consistently
Table 4 Descriptive statistics of standardised mortality rates for
cerebrovascular diseases for women in the Slovak Republic
Indicator 1996–2001 2002–2007 2008–2013
Minimum 110.44 83.79 89.78
Maximum 227.15 183.33 183.33
Median 153.41 142.90 151.63
Mean 156.25 140.17 150.36
Standard deviation 36.07 30.93 28.16
Coefficient of variation 23.08 22.07 18.73
Source: based on own elaboration by the authors
showed values lower than the median throughout the
whole time span. The standard deviation as well as the
coefficient of variation showed a downward trend. As for
women, the rates of variability gained the highest values in
the Prešov Region, at a level of 25.87, and in the Bratislava
Region, at a level of 25.69. On the contrary, the lowest val-
ues are found in the Trnava Region, at a value of 14.12, and
in the Žilina Region, reaching a value of 15.33.
To clearly show the regional disparities, Figs. 4 and 5
represent the status of the Slovak regions in terms of their
average standardised mortality rates for cerebrovascular
diseases during the whole time span, both for men and
women. The worst values were observed in the south-
ern regions – namely, the Nitra Region and the Banská
Bystrica Region. In contrast, better results were associ-
ated with northern Slovakia – the Žilina Region and the
Prešov Region – and the most favourable standardised
mortality rate for cerebrovascular diseases occurred in the
Bratislava Region. It is remarkable to observe the north-
ern regions with lower standardised mortality rates and
the southern regions with higher standardised mortality
rates. These differences likely relate to the risk factors, the
Table 3 Standardised mortality rate per 100,000 inhabitants for cerebrovascular diseases for women in the regions of the Slovak




SMR Rank SMR Rank Change SMR Rank Change
BC 227.15 8th 159.14 6th −29.94% 167.45 6th 5.22% 21.38
BL 128.20 2nd 83.79 1st −34.64% 89.78 1st 7, 16% 25.69
KI 141.56 4th 149.35 5th 5.51% 150.54 4th 0.79% 22.05
NI 171.61 7th 183.33 8th 6.83% 183.33 8th 0% 17.91
PV 110.44 1st 113.88 2nd 3.11% 152.71 5th 34.10% 25.87
TA 170.73 6th 161.75 7th −5.26% 170.67 7nd 5.51% 14.12
TC 165.27 5th 136.44 4th −17.44% 146.02 3th 7.02% 16.69
ZI 135.01 3rd 133.69 3rd −0.98% 142.38 2rd 6.50% 15.33
Legend: SMR standardised mortality rate, BC the Banská Bystrica Region, BL the Bratislava Region, KI the Košice Region, NI the Nitra Region, PV the Prešov Region, TA the
Trnava Region, TC the Trencín Region, ZI the Žilina Region
Note: Change is computed as period-over-period change
Source: based on own elaboration by the authors
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Fig. 4 Average level of standardised mortality rate per 100,000 inhabitants for cerebrovascular diseases for men in the regions of the Slovak Republic
from 1996 to 2013
socio-economic indicators and the environmental factors
influencing cerebrovascular diseases in these individual
regions.
Regression analysis
The examined models are presented in Table 5. Fitted
coefficients and p-values are displayed for each variable
involved in the particular model.
The following Table 6 demostrates the quantified stan-
dardised beta coefficients for the explanatory variables of
the regression models.
The subsequent Table 7 visualises significance of the
quantified variables involved in the regression models in
form of p-value.
The first model series represents a model set express-
ing the standardised mortality rate by all the variables
except for the constant value. The first two models –
M1 and M2 – were part of this series. In the first
step, the poverty indicator was deleted from the mod-
elling process as the variable with the worst p-value. The
best model in this series was represented by the second
model,M2.
Fig. 5 Average level of standardised mortality rate per 100,000 inhabitants for cerebrovascular diseases for women in the regions of the Slovak
Republic from 1996 to 2013
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Table 5 Beta coefficients
Coefficient M1 M2 M3 M4
β0 −410.606 −594.3626
UR 0.0659 0.0587 0.2213 0.0551
I 0.0819 0.0134 0.8793
P 0.2529 0.68 0.0279
GC 0.0206 0.0042 0.3616 0.0315
IQR 0.0113 0.0034 0.4439 0.0269
SB 0.0784 0.0659 0.2365 0.0654
Source: based on own elaboration by the authors
TheM2 model explained the standardisedmortality rate
as follows:
M2 = − 1.9361UR − 3.8777I + 6.5488GC − 5.5587IQR
+ 1.3006SB
(2)
The coefficient of determination of this model reached
a value of 0.9557, and although the adjusted coefficient of
determination declined to 0.3584, the dataset can be con-
sidered well fitted by the model M2. The model’s p-value
for F statistics was 0.0311. The choice of the secondmodel
M2 was also confirmed by the bayesian information cri-
terion, which reached −5.10 in the model M2, whereas
the corresponding value for the first modelM1 was−2.97.
The Akaike information criterion further confirmed this
situation, as its value for the first model M1 was 297.13
and was 240.41 for the second model M2. Moreover, all
the included variables fulfilled at least the ten-percent sig-
nificance level with only two dimensions – unemployment
rate and social benefits – slightly overstepping the five-
percent significance level. The Gini coefficient had the
largest impact on mortality rate, with a beta coefficient
reaching 6.5488. The income quintile share ratio had the
next largest effect, with a value of −5.5587, followed by
income with a value of 3.8777, unemployment rate with a
value of −1.9361 and finally social benefits with a value of
1.3006.
Table 6 Standardised beta coeffcients
Variable M1 M2 M3 M4
β0 2.2240 × 10−15 2.6543 × 10−15
UR −2.1068 −1.9361 −2.1068 −2.1489
I −1.0149 −3.8777 −1.0149
P 1.7317 1.7317 2.3268
GC 9.8444 6.5488 9.8444 10.927
IQR −10.1619 −5.5587 −10.162 −11.709
SB 1.3940 1.3006 1.3940 1.4170
Source: based on own elaboration by the authors
Table 7 Significance of variables
Variable M1 M2 M3 M4
β0 0.7488 0.072
UR 0.0659 0.0587 0.2213 0.0551
I 0.0819 0.0134 0.8793
P 0.2529 0.68 0.0279
GC 0.0206 0.0042 0.3616 0.0315
IQR 0.0113 0.0034 0.4439 0.0269
SB 0.0784 0.0659 0.2365 0.0654
Source: based on own elaboration by the authors
The second model series was based on the previous one
with only one alternation – a constant value in the form
of the intercept was added. In the first step, income was
removed from the modelling process because its p-value
was the highest of all the involved variables. The second
model of the series was again the best, although it can-
not be taken into consideration, because only the correct
constant value would remain in the successive step of the
modelling process.
M4 = 2.6543 × 10−15 −2.1489UR + 2.3268P +10.927GC
− 11.709IQR + 1.4170SB
(3)
Model M4 fits the dataset well; this was confirmed by
the coefficient of determination, which reached a value
of 0.9824, and its adjusted version, showing a value of
0.2456. The model itself fulfilled the five-percent signifi-
cance level, with a p-value for F statistics of 0.0433. There-
fore, continuing this modelling process was pointless. The
bayesian information criterion expressed the same result
– the value for the third model M3 was −0.55, whereas it
was −2.97 for the fourth modelM4. The Akaike informa-
tion criterion further confirmed this situation – the third
modelM3 had a value of 231.50 and the fourth modelM4
a value of 231.00.
Discussion
The variability of the standardised mortality rate gradu-
ally declined during the given time periods. The worst
standardised mortality rates were recorded in the Banská
Bystrica Region as well as in the Nitra Region, and the
best value was recorded in the Bratislava Region through-
out the explored time span. The standardised mortality
rate values were lower in the northern part of the Slovak
Republic compared with the southern part of the country.
However, the Bratislava Region and also the Prešov Region
showed the highest variability in standardised mortality
rate. In contrast, the lowest variability was typical for
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the Žilina Region and the Trnava Region. Although the
Bratislava Region was considered the best in terms of
mortality rate, the variability results in this region demon-
strated high volatility in positive results. However, the
Žilina Region showed a high level of stability of posi-
tive results regarding mortality rate. As for men, only the
Banská Bystrica Region showed a permanent percentage
drop in standardised mortality rate between the observed
time periods, while the opposite tendency was indicated
in the Košice Region, the Nitra Region, and in the Prešov
Region. The other regions demonstrated a volatile devel-
opment rate. As for women, a permanent percent increase
in standardised mortality rate was observed in the Košice
Region and Prešov Region.
The regression analysis revealed several dimensions that
had an impact on standardised mortality rate. Of all the
examined variables, unemployment rate, household dis-
posable income and income quintile ratio had a negative
impact, helping to reduce the mortality rate. However, at-
risk-of-poverty status, Gini coefficient and social benefits
positively influenced mortality rate. All these dimensions
appeared statistically significant and reliably described the
standardised mortality rate.
From the perspective of the indicators examined in
this study, mortality rate can be described by unemploy-
ment rate, household disposable income, share of at-risk-
of-poverty population, Gini coefficient, income quintile
ratio, and social benefits. This finding was statistically
confirmed. The factor with the largest influence was
income quintile ratio, which had the highest beta coef-
ficient in the model M4 that can be regarded as being
the most meaningful model than others, since the sec-
ond model series - the models M3 and M4 - contains the
intercept β0. Based on this finding, we suggest consid-
ering income quintile ratio within the Slovak population
when arranging out-of-pocket payments to ensure that
low-income groups are not at risk due to high payments
for delivered health care.
Slovakmen recorded higher values of standardisedmor-
tality rate by nearly 33% compared with women. However,
an average decline of 24% in standardised mortality rate
was observed for both sexes from 1996 to 2013. The
reason for the sharp increase in mortality from 2006 to
2008 is described in a study by Hlavatý and Liptáková
[26]. They revealed that in 2005 and 2006, the absolute
number of deaths for cerebrovascular diseases, marked
as I60 to I69 according to the World Health Organiza-
tion’s International Statistical Classification of Diseases,
was undervalued by 50% in favour of deaths for hyper-
tension, which were marked as I10 to I15, due to an
incorrect coding of the causes of death in statistical pro-
cessing. After 2006, the National Health Information Cen-
tre conducted a revision of the coding, leading to a sharp
increase in deaths from cerebrovascular diseases. Since
2007, all causes of deaths have been coded according
to international recommendations by Eurostat and the
World Health Organization documented in the Manual
on the certification of causes of death in Europe [27]. The
greatest difference between men and women occurred
in 2007, while the smallest gap was revealed in 2013.
The incidence of mortality for cerebrovascular diseases
has shifted to higher ages over the years. People at the
highest risk were in the age group of 70 to 84 years
from 1996 to 2001 and from 75 to 84 years from 2002
to 2013.
A limitation of this study is the lack of availability of
data on individual income level in the mortality database,
and thus summarymeasures for income indicators in each
region were applied.
The variability in mortality rate development in each
year shows that the development of mortality should also
be examined in terms of regional disparities to reflect
the factors strongly contributing to the development in
mortality rate in individual regions [28, 29]. By mapping
regional disparities, prevention programmes and other
interventions that could regulate mortality in individual
regions can be effectively established. By implementing
active prevention programmes targeted to selected pop-
ulation groups as well as to particular regions, mortality
and morbidity can be actively controlled, and these pro-
grams also contribute to increase the effectiveness of the
health system [30, 31].
Many educational activities devoted to prevention pro-
grammes for cerebrovascular disease risk factors are
clearly priorities of the health policy in the Slovak
Republic, namely the Monika project [32], the Cindi
project [33], the National Programme of Prevention Heart
Conditions in Adults [34], and the National Action Plan
for the prevention of obesity for the years 2015–2025 [35].
Their aim is to ensure effective long-term education of the
population at all societal levels.
As for international comparisons, the standardisedmor-
tality rate for cerebrovascular diseases in the Slovak pop-
ulation showed alarming values in comparison with the
entire European Union average. Many studies [36–38]
have shown that there is a diversity of health policy
approaches to reducing the incidence of risk factors affect-
ing cerebrovascular diseases, such as unhealthy lifestyles,
smoking, and obesity as well as lower access to health care
associated with the population’s socio-economic status.
Carefully prepared mortality analyses can provide a
valuable platform for developing the methodology of
avoidable mortality, which currently is solely dependent
on the health systems of interest to its creators [24, 39, 40].
The results of the available methodologies of avoidable
mortality [41] warrant caution in their interpretation
because each one has a specific methodology and inclu-
sion or exclusion diagnoses. According to many authors
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[8, 42, 43], mortality provides a reliable picture of pub-
lic health and is also the most objective way of measuring
health.
Conclusion
To conclude, at the present time, the mortality rate for
cerebrovascular diseases has decreased in many European
Union countries as well as in Slovakia.
Mortality is characterised by a relatively large amount of
inertia in its development, and therefore, it is not expected
that the described differences between the Slovak
Republic population and that of the other European coun-
tries will be diminished in the next few years. In our
study, we present an evaluation of the development of
mortality rates for cerebrovascular diseases in the Slovak
Republic. In addition, our objective was to quantify the
regional disparities and to analyse the development of the
mortality rate in relation to income inequalities in the
individual regions of the Slovak Republic. Income quin-
tile ratio appears to be the most influencing dimension
in these models of standardised mortality rate. Consid-
ering the process of demographic ageing as well as the
increase in the number of older people in the European
Union and worldwide, responsibility for health should be
prioritised.
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